MEMANTINE ATTENUATES THE OKADAIC ACID INDUCED SHORT-TERM SPATIAL MEMORY IMPAIRMENT AND HIPPOCAMPAL CELL LOSS IN RATS

Area of Science:

• Neuroscience
• Pharmacology
• Neurodegenerative Diseases

Background:

• Okadaic Acid (OA) induces spatial short-term memory impairment and hippocampal neurodegeneration.
• Alzheimer's disease (AD) pathology involves similar neurodegenerative processes.

Purpose of the Study:

• To investigate the neuroprotective effects of memantine on OA-induced memory deficits and hippocampal damage.
• To evaluate memantine as a potential therapeutic agent for AD-related pathology.

Main Methods:

• Rats received bilateral ICV injections of OA or artificial cerebrospinal fluid (aCSF).
• Subgroups were treated daily with memantine (5 mg/kg) or saline for 13 days.
• Spatial short-term memory was assessed using a spatial alternation task.
• Hippocampal neuroprotection was evaluated via Nissl staining to count surviving pyramidal neurons.

Main Results:

• ICV microinjection of OA significantly impaired spatial short-term memory in rats.
• OA administration led to a significant decrease in hippocampal CA1 pyramidal neuron survival.
• Chronic memantine treatment effectively reversed OA-induced memory impairment and neuropathological changes.

Conclusions:

• Intracerebroventricular (ICV) injection of OA serves as a valid experimental model for studying neurodegeneration.
• Memantine demonstrates significant neuroprotective potential against OA-induced hippocampal damage and memory loss.
• This study highlights potential therapeutic targets for AD pathology.